Mitral valve repair: What the ACORN trial taught us

被引：3
|
作者：
Ali M.W. [1 ]
Bolling S.F. [1 ]
机构：
[1] Department of Surgery, Section of Cardiac Surgery, University of Michigan, Ann Arbor, MI 48109
来源：
Current Cardiology Reports | 2010年 / 12卷 / 2期
关键词：
ACORN; Heart failure; Mitral valve;
D O I：
10.1007/s11886-010-0088-7
中图分类号：
学科分类号：
摘要：
Progressive left ventricular remodeling is characterized by dilation of the left ventricle with a change in the heart from an elliptical shape to a more spherical shape. This change is part of the unfavorable natural history in patients with heart failure. The CorCap Cardiac Support Device (Acorn Cardiovascular, St. Paul, MN) is a mesh device that is implanted around the heart to reduce wall stress and the first therapy specifically designed to address left ventricular remodeling. The CorCap was studied in a large, prospective, randomized, multicentered trial. This study demonstrated safety and effectiveness of the CorCap in patients with advanced heart failure and remodeled ventricles. Moreover, it provided interesting insights into mitral valve surgery in patients with heart failure. These insights and a review of the ACORN (Assessment of a Cardiac Support Device [CSD] in Patients With Heart Failure) trial are discussed in this article. © Springer Science+Business Media, LLC 2010.
引用
收藏
页码：116 / 121
页数：5
相关论文
共 50 条
  • [31] Acute Effect of Mitral Valve Repair on Mitral Valve Geometry
    Noack, Thilo
    Wittgen, Kathleen
    Kiefer, Philipp
    Emrich, Fabian
    Raschpichler, Matthias
    Eibel, Sarah
    Holzhey, David
    Misfeld, Martin
    Mohr, Friedrich-Wilhelm
    Borger, Michael
    Ender, Joerg
    Seeburger, Joerg
    [J]. THORACIC AND CARDIOVASCULAR SURGEON, 2019, 67 (07): : 516 - 523
  • [32] Mitral regurgitation - What causes the leakage is fundamental to the outcome of valve repair
    Enriquez-Sarano, M
    Schaff, HV
    Frye, RL
    [J]. CIRCULATION, 2003, 108 (03) : 253 - 256
  • [33] Mitral valve repair in patients with rheumatic heart disease: What are the limits?
    Schaff, Hartzell V.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2015, 149 (03): : 779 - 780
  • [34] TRENDS OF PRIMARY TRANSCATHETER MITRAL VALVE REPAIR VERSUS SURGICAL MITRAL VALVE REPAIR
    Tandon, Varun
    Balan, Prakash
    Freiman, Samuel Unzek
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 882 - 882
  • [35] A Trial of Two Anesthetic Regimes for Minimally Invasive Mitral Valve Repair
    Moscarelli, Marco
    Terrasini, Nora
    Nunziata, Anna
    Punjabi, Prakash
    Angelini, Gianni
    Solinas, Marco
    Buselli, Alba
    Del Sarto, Paolo
    Haxhiademi, Dorela
    [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2018, 32 (06) : 2562 - 2569
  • [36] Targeting inflammation—what has the VISTA-16 trial taught us?
    Michelle L. O'Donoghue
    [J]. Nature Reviews Cardiology, 2014, 11 : 130 - 132
  • [37] Why the prostate arm of the PLCO trial failed and what it has taught us
    Matthew R. Cooperberg
    [J]. Nature Reviews Urology, 2016, 13 : 439 - 440
  • [38] Percutaneous mitral valve repair for mitral regurgitation
    Chmielak, Zbigniew
    [J]. POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2007, 3 (02): : 91 - 96
  • [39] Mitral valve repair in the treatment of mitral regurgitation
    Carabello B.A.
    [J]. Current Treatment Options in Cardiovascular Medicine, 2009, 11 (6) : 419 - 425
  • [40] Mitral valve repair for ischemic mitral regurgitation
    Calafiore, Antonio M.
    Iaco, Angela L.
    Contini, Marco
    Bivona, Antonio
    Varone, Egidio
    Greco, Patrizia
    Scandura, Salvatore
    Di Mauro, Michele
    [J]. ANGIOLOGY, 2008, 59 : 89S - 92S
12345